Galson Steven K bought BCRX
June 11, 2026 · Form 4 insider transaction
Galson Steven K bought 15,294 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,294
Price
$0.00
Total value
N/A
InsiderGalson Steven K
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 15, 2026
Shares owned after27,794
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.